We are here to transform mental health and dementias research through data
Akrivia Health was born of a simple but urgent question: why is mental health and dementias research still decades behind other fields of medicine?
Beginning as UK-CRIS in 2009, and spinning out of the NHS and Oxford University in 2019, it became our sole mission to change this — by unlocking the full potential of real-world data to accelerate breakthroughs in neuropsychiatry and neurodegeneration.
Too often, conditions like schizophrenia, bipolar disorder, depression, and dementias are treated as monoliths. But the reality is more complex. Patients experience these illnesses differently, and treatments work differently too. The future lies in recognising these subtypes and tailoring interventions with precision.
This is where we come in.
We are curating the world’s most in-depth mental health and dementias dataset — linking structured and unstructured data from electronic health records with longitudinal, clinico-genomic insights. Our proprietary AI engine uses advanced natural language processing to extract deep phenotypic insights from decades of clinical notes — making the invisible, visible.
From drug discovery to service evaluation, we empower researchers, healthcare providers, and pharmaceutical partners to:
- Understand real-world disease burden and treatment response
- Identify better trial candidates and therapeutic targets
- Track outcomes, improve pathways, and evaluate efficacy
- Accelerate precision medicine in mental health and dementias
Akrivia Health doesn’t just provide data — we deliver the clarity and context needed to drive real change in this space. Because better data leads to better science. And better science leads to better care.
Stay in the know
Latest Akrivia Updates
Contact us
If you’d like to know how we can support you on a clinical trial or project, you’d like to become a healthcare partner, or you’d like to join our global community, get in touch today.